Eva Corey

72PUBLICATIONS
433CO-AUTHORS
Medical infection agents (incl. prions)Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (72)

|Jul 28, 2026
A genome-wide CRISPR screen in human prostate cancer cells reveals drivers of macrophage-mediated cell killing and positions AR as a tumor-intrinsic immunomodulator.

|Jul 15, 2026
Glutamate Ionotropic Kainate Receptors as Therapeutic Targets in Enzalutamide-Resistant and Neuroendocrine Prostate Cancer.

|May 26, 2026
Integrative Surface Antigen Profiling of KLK2 and STEAP1 in Advanced Prostate Cancer.

|May 12, 2026
TMPRSS2-ERG confers resistance of prostate cancer to antiandrogens.

|Feb 14, 2026
FOXJ1 mediates taxane resistance through regulation of microtubule dynamics.

Fang Xie, Ada Gjyrezi, Daniel Fein

|Jan 27, 2026
Lack of synergy between AR-targeted therapies and PARP inhibitors in homologous recombination-proficient prostate cancer.

Nicole A Traphagen, Esmé Wheeler, Rong Li

Pageof 12

Frequent Collaborators

15 joint publications

Peter S Nelson

8 joint publications

Michael C Haffner

7 joint publications

John K Lee

6 joint publications

Brian Hanratty